1. Transition from mesenchymal to bleb‐based motility is predominantly exhibited by CD133‐positive subpopulation of fibrosarcoma cells
   Aleksandra S. Chikina et al, 2019, Biology of the Cell CrossRef
2. Oncolytic virotherapy promotes radiosensitivity in soft tissue sarcoma by suppressing anti-apoptotic MCL1 expression
   Toshinori Omori et al, 2021, PLOS ONE CrossRef
3. Avaliação da imunomarcação de células-tronco tumorais em carcinossarcomas mamários e carcinomas em tumores mistos em cadelas
   Geórgia M. Magalhães et al, 2014, Pesquisa Veterinária Brasileira CrossRef
4. Soft Tissue Sarcoma Cancer Stem Cells: An Overview
   Katia C. Genadry et al, 2018, Frontiers in Oncology CrossRef
5. Human lung-derived mesenchymal stem cell-conditioned medium exerts in vitro antitumor effects in malignant pleural mesothelioma cell lines
   Lourdes Cortes-Dericks et al, 2016, Stem Cell Research & Therapy CrossRef
6. Overexpression of Oct4 suppresses the metastatic potential of breast cancer cells via Rnd1 downregulation
   Long Shen et al, 2014, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
7. A possible clinical benefit of the identification and characterization of colon cancer stem cells
   Maria Toloudi et al, 2015, Asian Pacific Journal of Tropical Disease CrossRef
8. Designing precision medicine panels for drug refractory cancers targeting cancer stemness traits
   Sudha Warrier et al, 2021, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
9. Mitochondrial DNA alterations may influence the cisplatin responsiveness of oral squamous cell carcinoma
   Amnani Aminuddin et al, 2020, Scientific Reports CrossRef
10. Three-dimensional and co-culture models for preclinical evaluation of metal-based anticancer drugs
    Ekaterina Schreiber-Brynzak et al, 2015, Investigational New Drugs CrossRef
11. Cancer Stem Cells in Soft-Tissue Sarcomas
    Paula Martínez-Delgado et al, 2020, Cells CrossRef
12. Complex Interplay of Genes Underlies Invasiveness in Fibrosarcoma Progression Model
    Michaela Kripnerová et al, 2021, Journal of Clinical Medicine CrossRef
13. Myrtucommulone-A treatment decreases pluripotency- and multipotency-associated marker expression in bladder cancer cell line HTB-9
    Banu Iskender et al, 2015, Journal of Natural Medicines CrossRef
14. In vitro and in vivo antitumor effects of the VO-chrysin complex on a new three-dimensional osteosarcoma spheroids model and a xenograft tumor in mice
    Ignacio E. León et al, 2016, JBIC Journal of Biological Inorganic Chemistry CrossRef
15. Evaluating of OCT-4 and NANOG was differentially regulated by a new derivative indole in leukemia cell line
    Mojgan Noroozi Karimabad et al, 2017, Immunology Letters CrossRef
16. Current diagnostics and treatment of fibrosarcoma -perspectives for future therapeutic targets and strategies
    Daniela Augsburger et al, 2017, Oncotarget CrossRef
17. Co-detection of ALDH1A1, ABCG2, ALCAM and CD133 in three A549 subpopulations at the single cell level by one-step digital RT-PCR
    Yanan Xu et al, 2018, Integrative Biology CrossRef
18. MicroRNA-542-3p inhibits oral squamous cell carcinoma progression by inhibiting ILK/TGF-β1/Smad2/3 signaling
    Bin Qiao et al, 2017, Oncotarget CrossRef
19. Tissue necrosis and its role in cancer progression
    Adi Karsch-Bluman et al, 2019, Oncogene CrossRef
20. Characterization of OCT3/4, Nestin, NANOG, CD44 and CD24 as stem cell markers in canine prostate cancer
    Camila Dorotea Costa et al, 2019, The International Journal of Biochemistry & Cell Biology CrossRef
21. B7-H1 enhances proliferation ability of gastric cancer stem-like cells as a receptor
    YUPENG YANG et al, 2015, Oncology Letters CrossRef
22. ADAMTS-1 disrupts HGF/c-MET signaling and HGF-stimulated cellular processes in fibrosarcoma
    Heydi Noriega-Guerra et al, 2018, Experimental Cell Research CrossRef